Association of Charcot-Marie-Tooth disease, Parkinson’s disease and FIG4 mutations
Objective: Here we report a patient with Charcot-Marie-Tooth (CMT) 4J disease (related to FIG4 mutations) who developed an early-onset Parkinson’s disease during evolution. Background: FIG4 encodes…Three cases of early tremor in the course of Guillain-Barré Syndrome
Objective: To report three cases of patients developing tremor in the course of Guillain-Barré Syndrome (GBS). Background: GBS is a monophasic neuropathy causing weakness and/or…Myokymia and Tremor-like Involuntary Movement in A Patient with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Objective: To illustrate the myokymia and tremor-like phenomenon in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Background: The clinical manifestations of CIDP are various and…Neurological complications secondary to metronidazole: Case Report
Objective: Present and discuss a case report showing neurotoxicity peripheral and central nervous system–associated with metronidazole use. Background: Due to the extensive clinical use of…Paresthesia and gait impairment in a patient with advanced Parkinson disease-case report
Objective: Our main objective is to illustrate different etiologies for paresthesia and gait impairment that can occur in a patient with Parkinson disease. We present…Rare ADCY6 variants in two families with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS)
Objective: To reveal a genetic cause for a syndrome of combined cerebellar ataxia, neuropathy and vestibular areflexia (CANVAS). Background: CANVAS is a clinically defined neurological…Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson’s disease patients: Bulgarian experience
Objective: To evaluate the efficacy of levodopa/carbidopa intestinal gel (LCIG) on motor fluctuations, dyskinesia, parkinson symptoms and quality of life in patients with late Parkinson’s…Management of chronic polyneuropathy associated with levodopa-carbidopa intestinal gel infusion in Parkinson’s disease: Review of the strategies and perspectives
Objective: (1) To make an inventory of the current strategies used to treat or prevent the occurrence of chronic polyneuropathy (CPN) in patients with Parkinson’s…Parkinson ‘ s disease and Peripheral Nervous System : Wax and Waning Non-motor offs and Levodopa-use Topics
Objective: To relate the non-motor offs theory , sensory signs and levodopa use with neurophysiiology terms in PD Background: Peripheral Nervous System disease concept in…Does levodopa-carbidopa intestinal gel in Parkinson’s disease patients increase the risk on polyneuropathy?
Objective: To analyze the influence of the overall levodopa exposure on the risk of polyneuropathy (PN) in levodopa-carbidopa intestinal gel (LCIG)-infusion treated patients with Parkinson’s…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.